Gsk Pharma

Sep 26, 2016 at 14:38 | Source:
With maintaining neutral rating on Glaxosmithkline Pharmaceutical, Credit Suisse slashed target price to Rs 2,850 as it continues to struggle with price control & supply constraints in some products. It also reduced FY17 earnings per share by 41 percent.
Sep 15, 2016 at 19:49 | Source:
Some investors shy away from buying stocks that have high prices. The belief is unfounded.
Jun 08, 2016 at 10:58 | Source: CNBC-TV18
Andrew Aristidou, CFO and ED Finance, GSK Pharma, speaks about the companys new launches and why GSK Pharma is in no rush to delist in India.
Mar 21, 2016 at 11:24 | Source: CNBC-TV18
Ajay Bodke of Prabhudas Lilladher is of the view that one can look at Ashok Leyland, Tata Motors, GlaxoSmithKline Consumer Healthcare, Britannia Industries and Sun Pharma.
Feb 11, 2016 at 08:13 | Source: CNBC-TV18
SBI | Tata Motors | HUL | Bharti Airtel | Cipla | ACC | Ambuja Cements | Emami | NHPC | Aurobindo Pharma | Visa Steel | Ruchi Soya | Venus Remedies | Financial Technologies | Tata Global | BL Kashyap | Asahi India Glass | IVRCL | Alstom T&D India | GSK Pharma and Capital First are stocks, which are in the news today.
Feb 10, 2016 at 17:00 | Source: CNBC-TV18
In an interview with CNBC-TV18, A Vaidheesh, VP, South Asia and MD of India GSK said that companys growth is in-line with the market and expects margins to outperform the industry average this fiscal.
Sep 30, 2015 at 19:22 | Source: PTI
The company has completed its transaction with Novartis Healthcare Pvt Ltd on Wednesday whereby it has acquired Novartis' vaccines business and divested its marketed oncology portfolio to Novartis India, GlaxoSmithKline Pharmaceuticals said in a filing to the BSE.
Sep 01, 2015 at 13:39 | Source: PTI
This acquisition fortifies the company's position with two opiates manufacturing facilities in Port Fairy and Latrobe (both in Australia) complementing its API manufacturing footprint globally, Sun Pharma said in a statement.
Sep 01, 2015 at 10:01 | Source:
"Sun Pharma today begins the integration of its Opiates business in Australia following the successful completion of this acquisition from GSK (announced in March 2015)," said the country's largest drug maker in its filing.
Sep 01, 2015 at 09:02 | Source:
Sun Pharmaceutical Industries, today begins the integration of its Opiates business in Australia following the successful completion of this acquisition from GSK.
Messages on Gsk Pharma »

MMB Messenger

Platinum Member



Will you bet on GSK Pharma?

2.38 PM Sep 26th

GlaxoSmithKline Pharmaceuticals  

gsk pharma can shine post march 2017

1.06 PM Sep 19th

BSE/NSE Announcer

Platinum Member



The Exchange has sought clarification from GlaxoSmithKline Pharmaceuticals Ltd on August 31, 2016 with reference to news flashed on CNBC TV18 dated August 31, 2016 stating "GSK Pharma invites bid for 60 acre land parcel in Thane, valued at 1400-1800 Cr"The reply is awaited.

12.41 PM Aug 31st


New Member


Standard Ind  

on CNBC today there is a news of gsk pharma likely to sell thane land to either rahejaa or pirnal. what is implications on standard Ind?

12.31 PM Aug 31st


Gold Member



stocks like GSK pharma, HUL, Castrol, Gail, like stocks are good. Who pay good dividend and also steady capital appreciation.

4.22 PM Feb 5th 2013

subodh I

Platinum Member


GMR Infra  

The prices of shares go to four digit figures even if it is out of F& O segment. Examples are: GSK Pharma; Bharat Electrical; TTK Prestige etc. If the scrip is fundamental support it will flourish. GVK Power also may go up if the projects on hand are commissioned and recycling of cash flow

2.26 PM Feb 5th 2013

Web Messenger

Platinum Member



Source:The Hindu BusinessLine - Mumbai, Feb. 3: Multinational drug-maker GlaxoSmithkline Pharmaceuticals is set to forge an “India-specific alliance”. The alliance will be for a product that is a “new area” for the company, GSK Pharma Managing Director (India), Dr Hasit Joshipura told Business

4.11 PM Feb 4th 2013


GSK Pharma to forge India-specific alliance - Reports Hindu BusinessLine. Good opportunity to grab GSK pharma now.

12.02 PM Feb 4th 2013

Web Messenger

Platinum Member


Pharmaceuticals - Sector  

Source:Business Standard - The Indian pharmaceutical industry is likely to see a dip in valuations in the near term as a result of the recent pricing policy that aims to intensify the regulatory hold over essential drugs. Profit of major drug makers, including that of GlaxoSmithKline (GSK) Pharma

3.41 PM Dec 21st 2012


Platinum Member



Buy Tata Global 169.85 with target of 250 for medium term. Buy GSK Pharma at 2050 with target of 2400

6.55 PM Dec 7th 2012

News across the web »
Dec 23, 2014 at 21:30 | Source: FirstPost
Aug 24, 2014 at 18:32 | Source: Economic Times
Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.